| Neuland Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524558 |
NSE Symbol : NEULANDLAB |
P/E(TTM) : 106.12 |
|
ISIN Demat : INE794A01010 |
Div & Yield% : 0.07 |
EPS(TTM) : 151.95 |
|
Book Value(₹) : 1,255.94 |
Market Cap(₹Cr) : 20,688.13 |
Face Value(₹) : 10.00 |
| Particulars | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | - | - | - | - | - |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,476.84 | 1,558.58 | 1,191.20 | 951.08 | 936.91 |
| Other Income | 96.91 | 12.54 | 9.75 | 2.08 | 16.09 |
| Stock Adjustments | -12.83 | 55.14 | 9.51 | 15.41 | 1.24 |
| Total Income | 1,560.92 | 1,626.26 | 1,210.46 | 968.57 | 954.24 |
| EXPENDITURE : | |||||
| Raw Materials | 578.45 | 636.49 | 491.98 | 441.79 | 443.04 |
| Power and Fuel Cost | 50.56 | 48.72 | 48.62 | 42.21 | 39.21 |
| Other Manufacturing Expenses | 108.66 | 103.73 | 82.69 | 84.92 | 73.71 |
| Selling and Administration Expenses | 120.52 | 104.29 | 88.50 | 70.50 | 79.80 |
| Miscellaneous Expenses | 22.11 | 10.04 | 22.77 | 9.12 | 11.93 |
| Employee Benefit Expenses | 261.40 | 248.53 | 194.84 | 175.76 | 144.02 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 419.22 | 474.47 | 281.06 | 144.27 | 162.54 |
| Interest | 8.30 | 14.00 | 13.07 | 13.49 | 17.90 |
| Gross Profit | 410.92 | 460.47 | 267.99 | 130.78 | 144.64 |
| Depreciation | 65.54 | 59.70 | 52.78 | 49.04 | 39.68 |
| Profit Before Tax | 345.38 | 400.77 | 215.21 | 81.74 | 104.96 |
| Current Tax | 73.65 | 99.59 | 50.39 | 20.42 | 12.48 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 12.29 | 1.59 | 1.70 | -2.22 | 12.18 |
| Reported Net Profit | 259.43 | 299.60 | 163.12 | 63.53 | 80.29 |
| Extraordinary Items | 51.90 | -0.30 | -0.66 | -1.36 | 9.81 |
| Adjusted Net Profit | 207.53 | 299.90 | 163.78 | 64.89 | 70.48 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit/Loss Balance carried down | 747.31 | 460.54 | 303.84 | 244.15 | 166.42 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 17.96 | 12.83 | 6.41 | 3.85 | 2.57 |
| P & L Balance carried down | 988.77 | 747.31 | 460.54 | 303.84 | 244.15 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 120.00 | 140.00 | 100.00 | 50.00 | 50.00 |
| Dividend Per Share(Rs) | 12.00 | 14.00 | 10.00 | 5.00 | 5.00 |
| Earnings Per Share-Unit Curr | 201.10 | 232.24 | 126.44 | 49.25 | 62.24 |
| Earnings Per Share(Adj)-Unit Curr | - | - | - | - | - |
| Book Value | 1,175.89 | 988.88 | 765.49 | 647.06 | 605.44 |
| Book Value(Adj)-Unit Curr | 1,175.89 | 988.88 | 765.49 | 647.06 | 605.44 |